Nuo Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.5M | $-2.3M | $-3.2M | $-3.2M | $-90.7K | $-90.9K | $-1.2M | $-1.5M |
| Depreciation & Amortization | — | — | — | — | $0 | $0 | $89.9K | $102.2K |
| Depreciation | $85.5K | $23.0K | $15.3K | $6.8K | $0 | — | — | $102.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $86.0K | $56.7K | $21.7K | $9.1K | $13.9K | $333.6K | $50.0K | $7.1K |
| Net Cash from Operating Activities | $-865.0K | $-2.2M | $-3.2M | $-3.7M | $-120.0K | $-53.8K | $-921.7K | $-874.4K |
| Investing Activities | ||||||||
| Capital Expenditures | $274.8K | $155.0K | $7.2K | $60.0K | $0 | $0 | $0 | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-274.8K | $-155.0K | $-7.2K | $-60.0K | $0 | $0 | $0 | $2.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.4M | $1.7M | $2.0M | $4.5M | $1.4M | $195.0K | $305.0K | $815.8K |
| Net Change in Cash | $265.2K | $-645.0K | $-1.2M | $691.6K | $1.3M | $141.2K | $-616.7K | $-56.6K |
| Free Cash Flow | $-1.1M | $-2.4M | $-3.2M | $-3.8M | $-120.0K | $-53.8K | $-921.7K | — |